1. Home
  2. PTGX vs GENI Comparison

PTGX vs GENI Comparison

Compare PTGX & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • GENI
  • Stock Information
  • Founded
  • PTGX 2006
  • GENI 2016
  • Country
  • PTGX United States
  • GENI United Kingdom
  • Employees
  • PTGX N/A
  • GENI N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • GENI Services-Misc. Amusement & Recreation
  • Sector
  • PTGX Health Care
  • GENI Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • GENI Nasdaq
  • Market Cap
  • PTGX 3.7B
  • GENI 3.0B
  • IPO Year
  • PTGX 2016
  • GENI N/A
  • Fundamental
  • Price
  • PTGX $61.69
  • GENI $12.54
  • Analyst Decision
  • PTGX Strong Buy
  • GENI Strong Buy
  • Analyst Count
  • PTGX 9
  • GENI 17
  • Target Price
  • PTGX $70.44
  • GENI $13.88
  • AVG Volume (30 Days)
  • PTGX 925.0K
  • GENI 4.6M
  • Earning Date
  • PTGX 11-06-2025
  • GENI 11-11-2025
  • Dividend Yield
  • PTGX N/A
  • GENI N/A
  • EPS Growth
  • PTGX N/A
  • GENI N/A
  • EPS
  • PTGX 0.80
  • GENI N/A
  • Revenue
  • PTGX $209,180,000.00
  • GENI $558,439,000.00
  • Revenue This Year
  • PTGX N/A
  • GENI $28.54
  • Revenue Next Year
  • PTGX $248.17
  • GENI $17.14
  • P/E Ratio
  • PTGX $73.55
  • GENI N/A
  • Revenue Growth
  • PTGX N/A
  • GENI 25.76
  • 52 Week Low
  • PTGX $33.31
  • GENI $6.72
  • 52 Week High
  • PTGX $61.89
  • GENI $13.73
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 61.74
  • GENI 50.64
  • Support Level
  • PTGX $57.90
  • GENI $12.08
  • Resistance Level
  • PTGX $60.40
  • GENI $12.61
  • Average True Range (ATR)
  • PTGX 2.47
  • GENI 0.41
  • MACD
  • PTGX 0.06
  • GENI -0.13
  • Stochastic Oscillator
  • PTGX 94.73
  • GENI 27.27

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About GENI Genius Sports Limited

Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.

Share on Social Networks: